← All stocks

Medtronic

MDT Net selling
CIK 0001613103 #310 in the set updated 19 Sep 2026
Bought (120 mo)
$7.20M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$181.08M
$1.04M on a plan · $150.39M straight out of an exercise
Sold at will
$29.65M
49 of 131 sales
Net
−$173.87M
−$22.44M against sales at will

By person

44 insiders · 172 transactions
21.9×

Geoff Martha holds 21.9 times base salary in stock. $30.70M of shares against $1.40M in salary for 2026.

Salary from the company's own proxy. The shares are what Geoff Martha last reported holding, valued at $93.65, the price Ordinary Shares was last bought or sold at on the open market here, on 16 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kuntz Richard
SVP & Chief Medical & Science
$24.98M (14) scheduled
−$24.98M
74,945
0.0059%
$7.02M
−39.9%
HAKAMI HOOMAN
EVP & Group President Diabetes
$23.08M (14) scheduled
−$23.08M
30,761
0.0024%
$2.88M
−51.8%
COYLE MICHAEL J
EVP & Group Pres, Cardiac&Vasc
$22.50M (8) scheduled
−$22.50M
190,390
0.0149%
$17.83M
+24.0%
Lerman Bradley E
SVP General Counsel & Corp Sec
$20.33M (10) scheduled
−$20.33M
48,635
0.0038%
$4.55M
−15.1%
ISHRAK OMAR
Executive Chairman
$2.01M (2)
$19.41M (3) scheduled
−$17.41M
575,582
0.0450%
$53.90M
+0.4%
WHITE ROBERT JOHN
EVP & Pres. Medical Surgical
$13.47M (11) scheduled
−$13.47M
49,910
0.0039%
$4.67M
+2.6%
Martha Geoffrey
Chairman and CEO
$11.90M (9) scheduled
−$11.90M
327,866
0.0256%
$30.70M
+403.5%
TEN HOEDT ROB
EVP and Pres. Global Regions
$8.49M (8) scheduled
−$8.49M
52,748
0.0041%
$4.94M
−5.0%
Salmon Sean
EVP & President Cardiovascular
$7.76M (6) scheduled
−$7.76M
64,722
0.0051%
$6.06M
+123.2%
KIIL HARRY SKIP
EVP & President Cardiovascular
$6.40M (10) scheduled
−$6.40M
42,186
0.0033%
$3.95M
+21.3%
Surface Carol A
EVP, Chief HR Officer
$5.34M (6)
−$5.34M
26,725
0.0021%
$2.50M
−63.6%
Hanson Bryan C
EVP, President, MITG
$4.90M (4)
−$4.90M
88,818
0.0069%
$8.32M
−43.0%
Liddicoat John R
EVP & President of Americas
$4.39M (1) scheduled
−$4.39M
37,374
0.0029%
$3.50M
−13.6%
Smith Gregory L
EVP Global Ops & Supply Chain
$3.90M (8)
−$3.90M
46,016
0.0036%
$4.31M
+36.6%
ANDERSON RICHARD H
Director
$3.34M (6)
+$3.34M
113,023
0.0088%
$10.58M
+63.1%
Wall Brett A.
EVP & Pres Neuroscience
$2.91M (8) scheduled
−$2.91M
82,183
0.0064%
$7.70M
+356.1%
POZEN ROBERT C
Director
$999.98K (1)
$308.74K (1) scheduled
+$691.24K
60,964
0.0048%
$5.71M
+11.6%
Jellison William R
Director
$462.75K (2)
+$462.75K
6,444
0.0005%
$603.48K
Walter Matthew R.
SVP, Chief HR Officer
$257.93K (1) scheduled
−$257.93K
39,928
0.0031%
$3.74M
+114.8%
PARKHILL KAREN L
EVP & Chief Financial Officer
$251.61K (1)
$452.89K (6)
−$201.28K
96,589
0.0075%
$9.05M
+39.8%
Marinaro Michael
EVP, Pres MedSurg and Americas
$184.72K (2) scheduled
−$184.72K
116,336
0.0091%
$10.89M
+334.4%
Lenehan James T
Director
$146.53K (1)
$109.12K (1) scheduled
+$37.41K
57,849
0.0045%
$5.42M
+42.5%
Ellis Gary Lee
EVP & Global Ops and IT
180,718
0.0141%
$16.92M
−5.2%
HOGAN RANDALL J
Director
85,796
0.0067%
$8.03M
+56.2%
OLEARY DENISE M
Director
77,057
0.0060%
$7.22M
+30.8%
Fong Ivan K
EVP GENERAL COUNSEL & SECR
54,692
0.0043%
$5.12M
+1,879%
Powell Kendall J
Director
51,380
0.0040%
$4.81M
+43.9%
Pieton Thierry
EVP & Chief Financial Officer
49,645
0.0039%
$4.65M
+2,944%
Corona Gary Louis
Interim CFO
44,255
0.0035%
$4.14M
+79.6%
ARNOLD CRAIG
Director
42,185
0.0033%
$3.95M
+130.8%
JACKSON SHIRLEY A
Director
38,525
0.0030%
$3.61M
+8.5%
Thompson Kweli
EVP & President, Neuroscience
35,390
0.0028%
$3.31M
+17.2%
Kirk Jennifer M
Chief Accounting Officer
28,011
0.0022%
$2.62M
+206.1%
Quinn Michelle
EVP, GC and Secretary
26,721
0.0021%
$2.50M
+3,734%
DONNELLY SCOTT C
Director
23,679
0.0018%
$2.22M
+199.5%
LEAVITT MICHAEL O
Director
21,779
0.0017%
$2.04M
+75.2%
NABEL ELIZABETH G
Director
19,584
0.0015%
$1.83M
+413.9%
Blomquist Denise L.
Chief Accounting Officer
16,398
0.0013%
$1.54M
+105.1%
Goldsmith Andrea Jo
Director
10,247
0.0008%
$959.63K
+2,762%
Lofton Kevin E
Director
10,140
0.0008%
$949.61K
+3,534%
Fonseca Lidia
Director
7,644
0.0006%
$715.86K
+3,007%
Lewis Gregory P
Director
5,754
0.0004%
$538.86K
+4,431%
Lee Joon Sup
Director
1,803
0.0001%
$168.85K
Groetelaars John P
Director
1,444
0.0001%
$135.23K
Insider
Date
Role
Action
Shares
Price
Amount
KIIL HARRY SKIP
19 Feb 2026
EVP & President Cardiovascular
Sold after exercise
385
$97.82
$37.66K
KIIL HARRY SKIP
19 Feb 2026
EVP & President Cardiovascular
Sold after exercise
668
$97.83
$65.35K
KIIL HARRY SKIP
19 Feb 2026
EVP & President Cardiovascular
Sold after exercise
19,255
$97.77
$1.88M
KIIL HARRY SKIP
19 Feb 2026
EVP & President Cardiovascular
Sold after exercise
30,568
$97.66
$2.99M
KIIL HARRY SKIP
19 Feb 2026
EVP & President Cardiovascular
Sold after exercise
1,648
$97.86
$161.27K
Wall Brett A.
24 Jan 2025
EVP & Pres Neuroscience
Sold after exercise
12,437
$90.00
$1.12M
Wall Brett A.
8 Jan 2025
EVP & Pres Neuroscience
Sold after exercise
3,000
$80.41
$241.23K
Wall Brett A.
8 Jan 2025
EVP & Pres Neuroscience
Sold after exercise
6,850
$80.41
$550.81K
Martha Geoffrey
7 Jun 2024
Chairman and CEO
Sold after exercise
1,594
$83.82
$133.61K
Martha Geoffrey
7 Jun 2024
Chairman and CEO
Sold after exercise
17,519
$83.76
$1.47M
Salmon Sean
21 Feb 2024
EVP & President Cardiovascular
Sold after exercise
16,035
$85.12
$1.36M
Salmon Sean
21 Feb 2024
EVP & President Cardiovascular
Sold after exercise
13,066
$85.15
$1.11M
Salmon Sean
21 Feb 2024
EVP & President Cardiovascular
Sold after exercise
1,594
$85.06
$135.59K
TEN HOEDT ROB
10 Jul 2023
EVP and Pres. Global Regions
Sold after exercise
3,706
$86.58
$320.87K
TEN HOEDT ROB
10 Jul 2023
EVP and Pres. Global Regions
Sold after exercise
1,808
$86.59
$156.55K
Salmon Sean
13 Dec 2022
EVP & President Cardiovascular
Sold after exercise
16,631
$80.50
$1.34M
TEN HOEDT ROB
14 Oct 2022
EVP and Pres. Global Regions
Sold after exercise
2,404
$81.54
$196.01K
Lerman Bradley E
30 Sep 2021
SVP General Counsel & Corp Sec
Sold after exercise
49,147
$126.58
$6.22M
Lerman Bradley E
31 Aug 2021
SVP General Counsel & Corp Sec
Sold after exercise
50,775
$134.17
$6.81M
Martha Geoffrey
25 Aug 2021
CEO
Sold after exercise
10,100
$132.67
$1.34M
Martha Geoffrey
25 Aug 2021
CEO
Sold after exercise
1,481
$132.67
$196.48K
Salmon Sean
25 Aug 2021
EVP & Pres Diabetes/Cardiovasc
Sold after exercise
7,290
$134.09
$977.52K
Salmon Sean
25 Aug 2021
EVP & Pres Diabetes/Cardiovasc
Sold after exercise
21,129
$134.08
$2.83M
Martha Geoffrey
28 Jun 2021
CEO
Sold after exercise
11,500
$125.29
$1.44M
Liddicoat John R
28 May 2021
EVP & President of Americas
Sold after exercise
34,656
$126.65
$4.39M
Martha Geoffrey
5 Apr 2021
CEO
Sold after exercise
9,308
$118.83
$1.11M
Martha Geoffrey
5 Apr 2021
CEO
Sold after exercise
2,404
$118.83
$285.67K
TEN HOEDT ROB
2 Mar 2021
EVP & President EMEA
Sold after exercise
7,168
$117.98
$845.68K
Lerman Bradley E
9 Nov 2020
SVP General Counsel & Corp Sec
Sold after exercise
20,715
$113.13
$2.34M
Lerman Bradley E
8 Oct 2020
SVP General Counsel & Corp Sec
Sold after exercise
797
$110.00
$87.67K
Lerman Bradley E
8 Oct 2020
SVP General Counsel & Corp Sec
Sold after exercise
19,917
$110.00
$2.19M
Kuntz Richard
24 Dec 2019
SVP & Chief Medical & Science
Sold after exercise
38,558
$113.56
$4.38M
Kuntz Richard
24 Dec 2019
SVP & Chief Medical & Science
Sold after exercise
1,808
$113.66
$205.50K
Kuntz Richard
24 Dec 2019
SVP & Chief Medical & Science
Sold after exercise
2,404
$113.60
$273.09K
Kuntz Richard
24 Dec 2019
SVP & Chief Medical & Science
Sold after exercise
3,019
$113.63
$343.05K
Kuntz Richard
24 Dec 2019
SVP & Chief Medical & Science
Sold after exercise
5,067
$113.64
$575.81K
WHITE ROBERT JOHN
2 Dec 2019
EVP & President MITG
Sold after exercise
12,583
$110.97
$1.40M
WHITE ROBERT JOHN
2 Dec 2019
EVP & President MITG
Sold after exercise
12,859
$110.28
$1.42M
WHITE ROBERT JOHN
2 Dec 2019
EVP & President MITG
Sold after exercise
13,240
$110.97
$1.47M
WHITE ROBERT JOHN
2 Dec 2019
EVP & President MITG
Sold after exercise
13,484
$110.29
$1.49M
COYLE MICHAEL J
15 Nov 2019
EVP & Group Pres, Cardiac&Vasc
Sold after exercise
3,797
$112.07
$425.53K
COYLE MICHAEL J
15 Nov 2019
EVP & Group Pres, Cardiac&Vasc
Sold after exercise
25,710
$111.31
$2.86M
COYLE MICHAEL J
15 Nov 2019
EVP & Group Pres, Cardiac&Vasc
Sold after exercise
7,367
$110.59
$814.68K
COYLE MICHAEL J
14 Nov 2019
EVP & Group Pres, Cardiac&Vasc
Sold after exercise
1,202
$109.95
$132.16K
COYLE MICHAEL J
14 Nov 2019
EVP & Group Pres, Cardiac&Vasc
Sold after exercise
900
$109.52
$98.57K
COYLE MICHAEL J
1 Nov 2019
EVP & Group Pres, Cardiac&Vasc
Sold after exercise
1,202
$109.50
$131.62K
COYLE MICHAEL J
1 Nov 2019
EVP & Group Pres, Cardiac&Vasc
Sold after exercise
37,774
$109.50
$4.14M
WHITE ROBERT JOHN
1 Nov 2019
EVP & President MITG
Sold after exercise
1,964
$109.66
$215.38K
WHITE ROBERT JOHN
1 Nov 2019
EVP & President MITG
Sold after exercise
3,349
$109.11
$365.42K
WHITE ROBERT JOHN
1 Nov 2019
EVP & President MITG
Sold after exercise
14,662
$109.67
$1.61M
WHITE ROBERT JOHN
1 Nov 2019
EVP & President MITG
Sold after exercise
28,428
$109.11
$3.10M
WHITE ROBERT JOHN
1 Nov 2019
EVP & President MITG
Sold after exercise
3,762
$109.66
$412.54K
HAKAMI HOOMAN
10 Sep 2019
EVP & Group President Diabetes
Sold after exercise
423
$107.22
$45.35K
HAKAMI HOOMAN
10 Sep 2019
EVP & Group President Diabetes
Sold after exercise
14,121
$107.41
$1.52M
HAKAMI HOOMAN
10 Sep 2019
EVP & Group President Diabetes
Sold after exercise
595
$107.22
$63.80K
HAKAMI HOOMAN
10 Sep 2019
EVP & Group President Diabetes
Sold after exercise
19,054
$107.41
$2.05M
HAKAMI HOOMAN
10 Sep 2019
EVP & Group President Diabetes
Sold after exercise
852
$107.22
$91.35K
HAKAMI HOOMAN
10 Sep 2019
EVP & Group President Diabetes
Sold after exercise
27,254
$107.28
$2.92M
HAKAMI HOOMAN
10 Sep 2019
EVP & Group President Diabetes
Sold after exercise
321
$107.22
$34.42K
HAKAMI HOOMAN
10 Sep 2019
EVP & Group President Diabetes
Sold after exercise
10,257
$107.31
$1.10M
HAKAMI HOOMAN
10 Sep 2019
EVP & Group President Diabetes
Sold after exercise
10,000
$107.09
$1.07M
HAKAMI HOOMAN
12 Jun 2019
EVP & Group President Diabetes
Sold after exercise
20,933
$97.49
$2.04M
HAKAMI HOOMAN
12 Jun 2019
EVP & Group President Diabetes
Sold after exercise
31,731
$97.49
$3.09M
Martha Geoffrey
24 Sep 2018
EVP & GroupPres Restora Therap
Sold after exercise
49,799
$97.93
$4.88M
HAKAMI HOOMAN
31 Aug 2018
EVP & Group President Diabetes
Sold after exercise
26,159
$96.29
$2.52M
Kuntz Richard
28 Aug 2018
SVP & Chief Medical & Science
Sold after exercise
47,176
$95.88
$4.52M
POZEN ROBERT C
23 Aug 2018
Director
Sold after exercise
3,218
$95.94
$308.74K
COYLE MICHAEL J
22 Aug 2018
EVP & Group Pres, Cardiac&Vasc
Sold after exercise
145,544
$95.50
$13.90M
Lenehan James T
13 Mar 2018
Director
Sold after exercise
1,306
$83.56
$109.12K
Surface Carol A
5 Mar 2018
SVP, Chief HR Officer
Sold after exercise
12,479
$78.36
$977.85K
Kuntz Richard
9 Jan 2018
SrVP & Chief Scien, Clin, Reg
Sold after exercise
78,526
$86.21
$6.77M
HAKAMI HOOMAN
5 Jan 2018
EVP & Group President Diabetes
Sold after exercise
26,158
$85.00
$2.22M
ISHRAK OMAR
15 Sep 2017
Chairman & CEO
Sold after exercise
140,407
$81.63
$11.46M
TEN HOEDT ROB
20 Mar 2017
EVP & President EMEA
Sold after exercise
50,757
$81.58
$4.14M
ISHRAK OMAR
15 Mar 2017
Chairman & CEO
Sold after exercise
95,000
$82.82
$7.87M
HAKAMI HOOMAN
2 Mar 2017
EVP & Group President Diabetes
Sold after exercise
52,316
$82.33
$4.31M
Kuntz Richard
26 Sep 2016
SrVP & Chief Scien, Clin, Reg
Sold after exercise
25,199
$86.67
$2.18M

What was left out

Form 4 filings counted 536
Amendments (4/A) skipped 13
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 77
Sales at will 49
Transactions with no price 0
Shares from compensation/vesting 5,260,393
Sales filed before the plan box existed 35
History held since 31 Aug 2016